3D Global Biotech (ROCO:6808) Accounts Payable & Accrued Expense : NT$47.80 Mil (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is 3D Global Biotech Accounts Payable & Accrued Expense?

3D Global Biotech's quarterly accounts payable & accrued expense increased from Jun. 2023 (NT$8.50 Mil) to Dec. 2023 (NT$12.56 Mil) and increased from Dec. 2023 (NT$12.56 Mil) to Jun. 2024 (NT$47.80 Mil).

3D Global Biotech's annual accounts payable & accrued expense increased from Dec. 2021 (NT$8.56 Mil) to Dec. 2022 (NT$10.57 Mil) and increased from Dec. 2022 (NT$10.57 Mil) to Dec. 2023 (NT$12.56 Mil).

3D Global Biotech Accounts Payable & Accrued Expense Historical Data

The historical data trend for 3D Global Biotech's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3D Global Biotech Accounts Payable & Accrued Expense Chart

3D Global Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

6.50

6.96

8.56

10.57

12.56

3D Global Biotech Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial								7.83	10.57	8.50	12.56	47.80

3D Global Biotech Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

3D Global Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Global Biotech Inc (ROCO:6808) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.99, Section 1, Xintai 5th Road, 21st Floor -3, Xizhi District, New Taipei, TWN, 221

Website

http://www.3dglobalbiotech.com.tw

3D Global Biotech Inc is engaged in developing reconstruction of human tissues and organs and manufactures customized and personalized high-level medical devices.

3D Global Biotech Headlines

No Headlines